期刊文献+

年龄对胰腺神经内分泌肿瘤患者术后生存的影响 被引量:8

Impact of age upon the prognosis of patients with pancreatic neuroendocrine tumors
原文传递
导出
摘要 目的研究和评价手术治疗胰腺神经内分泌肿瘤(pNETs)患者年龄与预后的关系。方法回顾性分析复旦大学附属中山医院1999年1月至2010年12月102例手术治疗pNETs患者的临床资料,通过镜下形态学以及对神经内分泌标记物嗜铬粒蛋白A、突触素和神经元特异性烯醇化酶等标志物免疫组织化学染色证实其为胰腺神经内分泌肿瘤。按照有丝分裂计数和Kj-67增殖指数确定肿瘤的分级;ENETSTNM系统确定肿瘤的分期;按年龄是否〉60岁将患者分为低龄组(H60岁,77例)和高龄组(〉60岁,25例)。采用寿命表法估计生存函数和计算生存率;Kaplan—Meier法绘制生存曲线;生存情况的比较用Log—rank检验;Kaplan—Meier法进行单因素生存分析;单因素COX分析计算风险率;COX比例风险模型筛选预后因素。结果全组患者总的中位生存时间为139.8个月;1、2、5及10年生存率分别为96%、93%、90%和80%。行根治术pNETs低龄组患者的术后生存时间显著优于高龄组患者(X^2=4.717,P〈0.05)。WHO分级较高(G2、G3级)和TNM分期较高(Ⅲ、Ⅳ期)的pNETs高龄组患者手术治疗的预后较低龄组差(X^2=11.158,5.375,P〈0.05)。多因素分析结果显示,年龄和大血管侵犯是影响患者预后的独立因素(艘=8.626,12.795,P〈0.05)。结论年龄〉60岁是影响pNETs患者术后预后的重要独立危险因素。肿瘤病理分期、分级与其预后有密切联系。 Objective To analyze the relationship between age and the prognosis of patients with pancre- atic neuroendocrine tumors (pNETs). Methods The clinical data of 102 patients with pNETs who were admitted to the Zbongshan Hospital of Fudan University from January 1999 to December 2010 were retrospectively analyzed. The properties of the tumors were determined by morphology and immunohistochemical staining of chromogranin A, synaptophysin and neuron-specific enolase. Preoperative grading of the tumors was done by mitotic count and Ki-67 proliferation index, and the staging of the tumors was done by ENETS TNM system. All patients were divided into younger group (age≤60 years, 77 patients) and older group (age 〉 60 years, 25 patients). The survival of the patients was estimated using the life table, and the survival curve was drawn by the Kaplan-Meier method. The survival of the 2 groups was compared using the Log-rank test. Multivariate analysis was performed with the COX proportional hazards model. Results The median survival time was 139.8 months. The overall 1-, 2-, 5-, and 10-year survival rates were 96% , 93% , 90% and 80% , respectively. The postoperative survival time of patients in the younger group was significantly longer than that in the older group ( X^2 = 4.717, P 〈 0.05 ). The prognosis of patients with higher tumor grades ( G2, G3 ) and higher TNM stages (Ⅲ,Ⅳ ) in the older group was signifi-cantly poorer than those in the younger group (X^2 = 11. 158, 5. 375, P 〈 0.05 ). The results of multivariate analysis showed that age and major vascular invasion were the independent predictors for survival (RR = 8. 626, 12. 795, P 〈 0.05). Conclusions Age above 60 years is an important independent factor influencing the prognosis of pNETs patients. Tumor grading and TNM staging are highly correlated with the prognosis of the pNETs patients.
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2012年第4期346-350,共5页 Chinese Journal of Digestive Surgery
基金 国家自然科学基金(81071740)
关键词 胰腺肿瘤 年龄 预后 生存分析 Pancreatic neoplasms Age Prognosis Survival analysis
  • 相关文献

参考文献14

  • 1Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, et al. Inci- dence, patterns of care and prognostic factors for outcome of gastro- enteropancreatic neuroendocrine tumors ( GEP-NETs ) : results from the National Cancer Registry of Spain (RGETNE). Ann Oncol,2010,21 (9) : 1794-1803.
  • 2Oberg K. Pancreatic endocrine tumors. Semin Oncol,2010,37(6) : 594-618.
  • 3Halfdanarson TR, Rubin J, Farnell MB, et al. Pancreatic endo- crine neoplasms: epidemiology and prognosis of pancreatic endo- crine tumors. Endocr Relat Cancer,2008,15(2) :409-427.
  • 4Grimelius E, Huhquist GT, Stenkvist B. Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch A Pathol Anat Histol, 1975,365 (4) :275-288.
  • 5Yao JC, Hassan M, Phan A, et al. One hundred years after "car- cinoid" : epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin 0ncol,2008, 26( 18 ) :3063-3072.
  • 6Bosman FT, Carneiro F, Hruban RH, et al. WHO Classification of the tumours of the digestive system. 4th ed. Lyon: IARC Press, 2010.
  • 7中国胃肠胰神经内分泌肿瘤病理学诊断共识[J].中华病理学杂志,2011,40(4):257-262. 被引量:291
  • 8Rindi G, Klfippel G, Alhman H, et al. TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grad- ing system. Virchows Arch ,2006,449 (4) :395-401.
  • 9Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 car- cinoid tumors. Cancer,2003,97 (4) :934-959.
  • 10Panzuto F, Boninsegna L, Fazio N, et al. Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin 0neol,2011,29 (17) : 2372-2377.

二级参考文献21

  • 1Goldin SB,Aston J,Wahi MM.Sporadically occurring functional pancreatic endocrine tumors:review of recent literature.Curr Opin Onco1,2008,20(1):25 -33.
  • 2Fidler JL,Fletcher JG,Reading CC,et al.Preoperative detection of pancreatic insulinomas on multiphasic helical CT.AJR Am J Roentgenol,2003,181 (3):775-780.
  • 3Mirallié E,Pattou F,Malvaux P,et al.Value of endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localization of insulinomas and gastrinomas experience of 54 cases.Gastroenterol Clin Biol,2002,26(4):360-366.
  • 4Ku YM,Shin SS,Lee CH,et al.Magnetic resonance imaging of cystic and endocrine pancreatic neoplasms.Top Magn Reson Imaging,2009,20(1):11-18.
  • 5Jackson JE.Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroeadocrine tumours.Best Pract Res Clin Eadocrinol Metab,2005,19 (2):229-239.
  • 6Won JG,Tseng HS,Yang AH,et al.Intra-arterial calcium stimulation test for detection of insulinomas:detection rate,responses of pancreatic pep tides,and its relationship to differentiation of tumor cells.Metabolism,2003,52(10):1320-1329.
  • 7Viola KV,Sosa JA.Current advances in the diagnosis and treatment of pancreatic endocrine tumors.Curr Opin Oncol,2005,17(1):24-27.
  • 8McAuley G,Delaney H,Colville J,et al.Multimodality preoperative imaging of pancreatic insulinomas.Clin Radiol,2005,60(10):1039-1050.
  • 9Yaov JC,Hassan M,Phan A,et al.One hundred years after "carcinoid ":epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.J Clin Oncol,2008,26(18):3063-3072.
  • 10Yao JC,Shah MH,Ito T,et al.Everolimus for advanced pancreatic neuroendocrine tumors.N Engl J Med,2011,364(6):514-523.

共引文献295

同被引文献102

  • 1孙惠川,汤敏,钦伦秀,王鲁,叶青海,任宁,樊嘉,曾蒙苏,汤钊猷.用余肝体积预测半肝切除耐受性的安全标准[J].中华肝胆外科杂志,2006,12(6):366-369. 被引量:24
  • 2Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours [ J ]. Lancet Oncol, 2008, 9( 1 ): 61-72.
  • 3Niederle MB, Haekl M, Kaserer K, et al. Gastroeuteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neurnendocrine Tumnur Soci- ety classification: an analysis based on prospectively collected parameters [ J ]. Endocr Relat Cancer, 2010, 17 (4): 909-918.
  • 4Delle Fave G, Kwekkeboom DJ, Van Cutsem E, et al. ENETS Consensus Guidelines for the management of patients with gas- troduodenal neoplasms [J]. Neuroendocrinology, 2012, 95 (2): 74-87.
  • 5Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system [M]. Lyon: International Agency for Research on Cancer, 2010: 13-47.
  • 6Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, et al. Inci- dence, patterns of care and prognostic factors for outcome of gas- troenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)[J]. Ann Oncol, 2010, 21(9): 1794-1803.
  • 7Yao JC, Hassan M, Phan A, et al. One hundred years after "car- cinoid": epidemiology of and prognostic factors for neuroendo- crine tumors in 35,825 cases in the United States[J]. J Clin On- col, 2008, 26( 18): 3063-3072.
  • 8Kulke MH. Are neuroendocrine tumors going mainstream? [J].J Clin Oncol, 2013, 31 (4): 404-405.
  • 9Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America[J]. Can- cer, 2008, 113( 10): 2655-2664.
  • 10Modlin IM, Pavel M, Kidd M, et al. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroen- docrine (carcinoid) tumours [J]. Aliment Pharmacol Thera, 2010, 31(2): 169-188.

引证文献8

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部